Andrew Stolz
- Pharmacology top 0.05%
- Oncology top 2%
- Epidemiology top 5%
- Molecular Biology top 10%
- Cell Biology top 2%
- Co-authors
- Robert J. FontanaNeil KaplowitzHuiman X. BarnhartHajime TakikawaPaul H. HayashiK. Rajender ReddyJosé SerranoDavid E. Kleiner
- Topics
- Drug-Induced Hepatotoxicity and Protection (37 papers)Drug Transport and Resistance Mechanisms (29 papers)Pharmacogenetics and Drug Metabolism (26 papers)
- Cited by
- PharmacologyHepatologyOncology
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationSHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Andrew Stolz
90 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Pharmacology 1.6k
- Oncology 986
- Epidemiology 788
- Molecular Biology 694
- Cell Biology 554
Countries citing papers authored by Andrew Stolz
This map shows the geographic impact of Andrew Stolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Stolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Stolz more than expected).
Fields of papers citing papers by Andrew Stolz
This network shows the impact of papers produced by Andrew Stolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Stolz. The network helps show where Andrew Stolz may publish in the future.
Co-authorship network of co-authors of Andrew Stolz
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Stolz. A scholar is included among the top collaborators of Andrew Stolz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Stolz. Andrew Stolz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 25 | |
| 6 | 6 | |
| 7 | 21 | |
| 8 | 36 | |
| 9 | 67 | |
| 10 | 7 | |
| 11 | Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Networkbreakdown → | 292 |
| 12 | 94 | |
| 13 | 52 | |
| 14 | Increasing AKR1C1 and AKR1C2 dependent DHT catabolism in prostate cancer (CaP) cell lines by Phase II Inducers can prevent DHT-dependent gene expression: implications for chemoprevention of CaP | 0 |
| 15 | 86 | |
| 16 | 21 | |
| 17 | 72 | |
| 18 | 59 | |
| 19 | 214 | |
| 20 | 24 |
About Andrew Stolz
Andrew Stolz is a scholar working on Pharmacology, Hepatology and Cell Biology, having authored 97 papers that have together received 3.6k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (37 papers), Drug Transport and Resistance Mechanisms (29 papers) and Pharmacogenetics and Drug Metabolism (26 papers). The work is most often cited by research in Pharmacology (1.6k citations), Hepatology (516 citations) and Oncology (986 citations). Andrew Stolz has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Robert J. Fontana, Neil Kaplowitz, Huiman X. Barnhart, Hajime Takikawa, Paul H. Hayashi, K. Rajender Reddy, José Serrano, David E. Kleiner, Victor J. Navarro and Jay H. Hoofnagle. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.